Jubilant Life Sciences zooms 7 per cent

Jubilant Life Sciences gained nearly 7 per cent in today's session over the announcement of termination of anti-dumping duty in China.

The integrated global Pharmaceutical and Life Sciences company announced on Wednesday that the Ministry of Commerce (MOFCOM), China, has decided to terminate the 17.6 per cent anti-dumping duty on imported pyridine, originating in India. Jubilant Life Sciences is a top manufacturer of Pyridine and its 14 derivatives.

Looking at the recently concluded quarter, that is, Q2FY20, the company’s consolidated revenue came in at Rs. 2,265.93 crores against Rs. 2,269.49 crores in the corresponding quarter last year, registering a 0.2 per cent YoY decline.

The EBITDA for the quarter in review grew by 4.1 per cent YoY to Rs. 468.45 crores against Rs. 450.18 crores in the corresponding quarter last year, with a corresponding margin expansion of 84 bps. The EBITDA margin for Q2FY20 stood at 20.7 per cent. PAT for the quarter came in at Rs. 249.39 crores against Rs. 209.77 crores in Q2FY19, registering a YoY increase of 18.9 per cent.